Diagnostic techniques for inflammatory eye disease: Past, present and future: A review

BMC Ophthalmology

Volumn 13, Issue 1, 2013, Pages

  Teoh, Stephen C ^a,b   Dick, Andrew D ^c,d  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b Mount Alvernia Hospital   (Singapore)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; Autoregulation; Cytokines; Diagnosis; Hypersensitivity; Immunoglobulin; Ocular inflammation; Polymerase chain reaction; Uveitis

Indexed keywords

EYE DISEASE; HUMAN; REVIEW; UVEITIS; VISUAL SYSTEM EXAMINATION;

DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EYE DISEASES; HUMANS; UVEITIS;

EID: 84881178584     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-13-41     Document Type: Article

References (120)

1. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Gritz DC, Wong IG, Ophthalmology 2004 111 491 500 10.1016/j.ophtha.2003.06.014 15019324 (Pubitemid 38293104)
2. Population-based prevalence of uveitis in Southern India. Rathinam SR, Krishnadas R, Ramakrishnan R, Thulasiraj RD, Tielsch JM, Katz J, Robin AL, Kempen JH, Comprehensive Eye Survey Research Group, Br J Ophthalmol 2011 95 463 467 10.1136/bjo.2010.182311 20693551
3. The possible impact of uveitis in blindness: a literature survey. Suttorp-Schulten MS, Rothova A, Br J Ophthalmol 1996 80 844 848 10.1136/bjo.80.9.844 8962842 (Pubitemid 26345317)
4. A cross-sectional study of the current treatment patterns in noninfectious uveitis among specialists in the United States. Nguyen QD, Hatef E, Kayen B, Macahilig CP, Ibrahim M, Wang J, Shaikh O, Bodaghi B, Ophthalmology 2011 118 184 190 10.1016/j.ophtha.2010.03.029 20678806
5. Emerging drugs for uveitis. Larson T, Nussenblatt RB, Sen HN, Expert Opin Emerg Drugs 2011 16 309 322 10.1517/14728214.2011.537824 21210752
6. Methotrexate for ocular inflammatory diseases. Gangaputra S, Newcomb CW, Liesegang TL, Kacmaz RO, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Kempen JH, Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study, Ophthalmology 2009 116 2188 2198 10.1016/j.ophtha.2009.04.020 19748676
7. Azathioprine for ocular inflammatory diseases. Pasadhika S, Kempen JH, Newcomb CW, Liesegang TL, Pujari SS, Rosenbaum JT, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Suhler EB, Am J Ophthalmol 2009 148 500 509 10.1016/j.ajo.2009.05.008 19570522
8. Rescue therapy with mycophenolate mofetil in refractory uveitis. Kilmartin DJ, Forrester JV, Dick AD, Lancet 1998 352 35 36 10.1016/S0140- 6736(05)79515-5 9800750 (Pubitemid 28306570)
9. Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Baltatzis S, Tufail F, Yu EN, Vredeveld CM, Foster CS, Ophthalmology 2003 110 1061 1065 10.1016/S0161-6420(03)00092-7 12750115 (Pubitemid 36560514)
10. Mycophenolate mofetil therapy for inflammatory eye disease. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP, Ophthalmology 2005 112 1472 1477 10.1016/j.ophtha.2005.02.020 16061096 (Pubitemid 41074642)
11. Mycophenolate mofetil for the treatment of uveitis. Teoh SC, Hogan AC, Dick AD, Lee RW, Am J Ophthalmol 2008 146 752 760 10.1016/j.ajo.2008.03.004 18455143
12. Cyclophosphamide for ocular inflammatory diseases. Pujari SS, Kempen JH, Newcomb CW, Gangaputra S, Daniel E, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Foster CS, Ophthalmology 2010 117 356 365 10.1016/j.ophtha.2009.06.060 19969366
13. Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis. Hogan AC, McAvoy CE, Dick AD, Lee RW, Ophthalmology 2007 114 1000 1006 10.1016/j.ophtha.2007.01.026 17467532 (Pubitemid 46635862)
14. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis. Murphy CC, Greiner K, Plskova J, Duncan L, Frost NA, Forrester JV, Dick AD, Arch Ophthalmol 2005 123 634 641 10.1001/archopht.123.5.634 15883282 (Pubitemid 40695511)
15. Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Kilmartin DJ, Forrester JV, Dick AD, Ocul Immunol Inflamm 1998 6 101 109 10.1076/ocii.6.2.101.4051 9689640 (Pubitemid 28380074)
16. Cyclosporine for ocular inflammatory diseases. Kaçmaz RO, Kempen JH, Newcomb C, Daniel E, Gangaputra S, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Foster CS, Ophthalmology 2010 117 576 584 10.1016/j.ophtha.2009.08.010 20031223
17. Biologics in the treatment of uveitis. Imrie FR, Dick AD, Curr Opin Ophthalmol 2007 18 481 486 10.1097/ICU.0b013e3282f03d42 18163000 (Pubitemid 351339402)
18. Gene therapy for noninfectious uveitis. Chu CJ, Barker SE, Dick AD, Ali RR, Ocul Immunol Inflamm 2012 20 394 405 10.3109/09273948.2012.726392 23163799
19. Biologic therapies for inflammatory eye disease. Lim L, Suhler EB, Smith JR, Clin Experiment Ophthalmol 2006 34 365 374 10.1111/j.1442-9071.2006.01225.x 16764659 (Pubitemid 44137557)
20. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Sfikakis PP, Curr Dir Autoimmun 2010 11 180 210 20173395
21. Infliximab therapy for refractory uveitis: 2-year results of a prospective trial. Suhler EB, Smith JR, Giles TR, Lauer AK, Wertheim MS, Kurz DE, Lim L, Mackensen F, Pickard TD, Rosenbaum JT, Arch Ophthalmol 2009 127 819 822 19506209
22. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Galor A, Perez VL, Hammel JP, Lowder CY, Ophthalmology 2006 113 2317 2323 10.1016/j.ophtha.2006.04.038 16996615 (Pubitemid 44838928)
23. High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Sen HN, Levy-Clarke G, Faia LJ, Li Z, Yeh S, Barron KS, Ryan JG, Hammel K, Nussenblatt RB, Am J Ophthalmol 2009 148 696 703 10.1016/j.ajo.2009.06.003 19664754
24. Tailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndrome. Teoh SC, Sharma S, Hogan A, Lee R, Ramanan AV, Dick AD, Br J Ophthalmol 2007 91 263 264 10.1136/bjo.2006.0101477 17244662 (Pubitemid 46202883)
25. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I, Arthritis Rheum 2010 62 2796 2805 10.1002/art.27581 20518075
26. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, du LT H, Lemaitre C, Fradeau C, LeHoang P, Piette JC, Br J Ophthalmol 2007 91 335 339 10.1136/bjo.2006.101550 17050581 (Pubitemid 46586530)
27. Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H. Isaacs JD, Hale G, Waldmann H, Dick AD, Haynes R, Forrester JV, Watson P, Meyer PA, Br J Ophthalmol 1995 79 1054 1055 10.1136/bjo.79.11.1054 8534657
28. Anti-TNF-alpha therapy for uveitis: Behçet and beyond. Murray PI, Sivaraj RR, Eye 2005 19 831 833 10.1038/sj.eye.6701792 16086039 (Pubitemid 41195133)
29. Retinopathy Study Group: A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ, UCLA CMV, Arch Ophthalmol 1989 107 1759 1766 10.1001/archopht.1989. 01070020841024 2556989 (Pubitemid 20013137)
30. Interplay between innate and adaptive immunity in the development of non-infectious uveitis. Willermain F, Rosenbaum JT, Bodaghi B, Rosenzweig HL, Childers S, Behrend T, Wildner G, Dick AD, Prog Retin Eye Res 2012 31 182 194 10.1016/j.preteyeres.2011.11.004 22120610
31. Epidemiology and Prevalence of Uveitis: Review of Literature. Chams H, Rostami M, Mohammadi SF, Ohno S, Iran J Ophth 2009 21 4 16
32. Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossmann syndrome. Bloch-Michel E, Dussaix E, Cerqueti P, Patarin D, Int Ophthalmol 1987 112 95 96 (Pubitemid 18071405)
33. Cytomegalovirus in aetiology of Posner-Schlossman syndrome: evidence from quantitative polymerase chain reaction. Teoh SB, Thean L, Koay E, Eye 2005 19 1338 1340 10.1038/sj.eye.6701757 15543169 (Pubitemid 43148514)
34. Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. Chee SP, Jap A, Am J Ophthalmol 2008 146 883 889 10.1016/j.ajo.2008.09.001 19027423
35. Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs' heterochromic cyclitis. Ruokonen PC, Metzner S, Ucer A, Torun N, Hofmann J, Pleyer U, Graefes Arch Clin Exp Ophthalmol 2010 248 565 571 10.1007/s00417-009-1239-7 19937050
36. Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. Suzuki J, Goto H, Komase K, Abo H, Fujii K, Otsuki N, Okamoto K, Graefes Arch Clin Exp Ophthalmol 2010 248 1487 1491 10.1007/s00417-010-1434-6 20585798
37. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Quentin CD, Reiber H, Am J Ophthalmol 2004 138 46 54 10.1016/j.ajo.2004.02.055 15234281 (Pubitemid 38850248)
38. Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic iridocyclitis. Barequet IS, Li Q, Wang Y, O'Brien TP, Hooks JJ, Stark WJ, Am J Ophthalmol 2000 129 672 673 10.1016/S0002-9394(00)00409-8 10844066 (Pubitemid 30323740)
39. Should we Investigator patients with Uveitis. Marr JE, Invest Ophthalmol Vis Sci 1998 39 608
40. Anterior uveitis investigation by Canadian ophthalmologists: insights from the Canadian National Uveitis Survey. Forooghian F, Gupta R, Wong DT, Derzko-Dzulynsky L, Can J Ophthalmol 2006 41 576 583 17016528 (Pubitemid 44638974)
41. The Interface between Adaptive and Innate Immunity. Hoebe K, Janssen E, Beutler B, Nature Immunol 2004 10 971 974
42. Old meets new: the interaction between innate and adaptive immunity. Clark R, Kupper T, J Invest Dermatol 2005 125 629 637 10.1111/j.0022-202X.2005. 23856.x 16185260
43. Innate immune responses to infection. Tosi MF, J Allergy Clin Immunol 2005 116 241 249 10.1016/j.jaci.2005.05.036 16083775 (Pubitemid 41096524)
44. Intraocular tuberculosis-an update. Gupta V, Gupta A, Rao NA, Surv Ophthalmol 2007 52 561 587 10.1016/j.survophthal.2007.08.015 18029267 (Pubitemid 350102547)
45. Ocular tuberculosis. Helm CJ, Holland GN, Surv Ophthalmol 1993 38 229 256 10.1016/0039-6257(93)90076-J 8310395 (Pubitemid 23362700)
46. Aqueous cytokine and chemokine analysis in uveitis associated with tuberculosis. Ang M, Cheung G, Vania M, Chen J, Yang H, Li J, Chee SP, Mol Vis 2012 18 565 573 22509092
47. Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection, United States. Recommendations and Reports. Centers for Disease Control and Prevention, MMWR 2010 59 1 25 RR5 21160459
48. Usefulness of QuantiFERON TB-2G: a diagnostic method for latent tuberculosis infection, in a contact investigation of health care workers. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Fujii M, Oka M, Intern Med 2007 46 1543 1549 10.2169/internalmedicine.46.0088 17878640 (Pubitemid 47521049)
49. Specific detection of tuberculosis infection. An interferon-γ-based assay using new antigens. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, Shigeto E, Harada N, Mitarai S, Okada M, Suzuki K, Inoue Y, Tsuyuguchi K, Sasaki Y, Mazurek GH, Tsuyuguchi I, Am J Respir Crit Care Med 2004 170 59 64 10.1164/rccm.200402-179OC 15059788 (Pubitemid 38997752)
50. Re-activation of bovine tuberculosis in a patient treated with infliximab. Larsen MV, Sørensen IJ, Thomsen VØ Ravn P, Eur Respir J 2008 32 229 231 10.1183/09031936.00125607 18591340
51. Atypical mycobacterial pulmonary disease and bronchial obstruction in HIV-negative children. Dore ND, LeSouëf PN, Masters B, Francis PW, Cooper DM, Wildhaber JH, Fall AJ, Sly PD, Pediatr Pulmonol 1998 26 380 388 10.1002/(SICI)1099-0496(199812)26:6<380::AID-PPUL2>3.0.CO;2-I 9888212 (Pubitemid 29024979)
52. Mantoux test and its interpretation. Nayak S, Acharjya B, Ind Dermatol Online J 2012 3 2 6 10.4103/2229-5178.93479
53. Non-tuberculous mycobacterial lymphadenitis. White MP, Bangash H, Goel KM, Jenkins PA, Arch Dis Child 1986 61 368 371 10.1136/adc.61.4.368 3707188 (Pubitemid 16085423)
54. Evidence-based comparison of commercial interferon-γ release assays for detecting active TB: a metaanalysis. Diel R, Loddenkemper R, Nienhaus A, Chest 2010 137 952 968 10.1378/chest.09-2350 20022968
55. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Ang M, Wong W, Ngan CC, Chee SP, Eye 2012 26 658 665 10.1038/eye.2012.1 22302066
56. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Vasconcelos-Santos DV, Zierhut M, Rao NA, Ocul Immunol Inflamm 2009 17 351 355 10.3109/09273940903168688 19831571
57. Serological changes in immunoglobulins IgG, IgA and IgM and Escherichia coli antibodies in the young pig. Hill IR, Immunology 1970 18 565 573 4986977
58. Demonstration of intraocular synthesis of immunoglobulin G toxoplasma antibodies for specific diagnosis of toxoplasmic chorioretinitis by enzyme immunoassay. Turunen HJ, Leinikki PO, Saari KM, J Clin Microbiol 1983 17 988 992 6348082 (Pubitemid 13098854)
59. Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitis. De Groot-Mijnes JD, Rothova A, Van Loon AM, Schuller M, Ten Dam-Van Loon NH, De Boer JH, Schuurman R, Weersink AJ, Am J Ophthalmol 2006 141 313 318 10.1016/j.ajo.2005.09.017 16458686 (Pubitemid 43188032)
60. New approaches to the detection of locally produced antiviral antibodies in the aqueous of patients with endogenous uveitis. Dussaix E, Cerqueti PM, Pontet F, Bloch-Michel E, Ophthalmologica 1987 194 145 149 10.1159/000309752 3302799 (Pubitemid 17079766)
61. Clinical implications of aqueous humor studies in uveitis. Witmer R, Am J Ophthalmol 1978 86 39 44 354395 (Pubitemid 8357351)
62. Aqueous humor analysis as a diagnostic tool in Toxoplasma uveitis. Kijlstra A, Luyendijk L, Baarsma GS, Rothova A, Schweitzer CM, Timmerman Z, de Vries J, Breebaart AC, Int Ophthalmol 1989 13 383 386 10.1007/BF02306485 2697703 (Pubitemid 20098981)
63. Usefulness of aqueous humor analysis for the diagnosis of posterior uveitis. Rothova A, de Boer JH, Ten Dam-van Loon NH, Postma G, de Visser L, Zuurveen SJ, Schuller M, Weersink AJ, van Loon AM, De Groot-Mijnes JD, Ophthalmology 2008 115 306 311 10.1016/j.ophtha.2007.05.014 17669497 (Pubitemid 351163363)
64. Contributions of immunoblotting, real-time PCR, and the Goldmann-Witmer coefficient to diagnosis of atypical toxoplasmic retinochoroiditis. Talabani H, Asseraf M, Yera H, Delair E, Ancelle T, Thulliez P, Brézin AP, Dupouy-Camet J, J Clin Microbiol 2009 47 2131 2135 10.1128/JCM.00128-09 19439541
65. Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. Villard O, Filisetti D, Roch-Deries F, Garweg J, Flament J, Candolfi E, J Clin Microbiol 2003 41 3537 3541 10.1128/JCM.41.8.3537-3541.2003 12904352 (Pubitemid 36994679)
66. Serum immunoglobulins in acute anterior uveitis. McCoy R, White L, Tait B, Ebringer R, Br J Ophthalmol 1984 68 807 810 10.1136/bjo.68.11.807 6333893 (Pubitemid 15146082)
67. Immunoglobulins in aqueous humour and iris from patients with endogenous uveitis and patients with cataract. Ghose T, Quigley JH, Landrigan PL, Asif A, Br J Ophthalmol 1973 57 897 903 10.1136/bjo.57.12.897 4207715
68. Serum immunoglobulin levels in endogenous uveitis: Before and after therapy. Sen DK, Sarin GS, Pal S, Sharma VK, Ind J Ophthalmol 1985 33 167 170
69. Identification of new pathogens in the intraocular fluid of patients with uveitis. de Groot-Mijnes JD, de Visser L, Zuurveen S, Martinus RA, Völker R, ten Dam-van Loon NH, de Boer JH, Postma G, de Groot RJ, van Loon AM, Rothova A, Am J Ophthalmol 2010 150 628 636 10.1016/j.ajo.2010.05.015 20691420
70. Chikungunya virus iridocyclitis in Fuchs' heterochromic iridocyclitis. Mahendradas P, Shetty R, Malathi J, Madhavan HN, Ind J Ophthalmol 2010 58 545 547 10.4103/0301-4738.71707
71. Comparison of rubella virus- and herpes virus-associated anterior uveitis: clinical manifestations and visual prognosis. Wensing B, Relvas LM, Caspers LE, Valentincic NV, Stunf S, de Groot-Mijnes JD, Rothova A, Ophthalmology 2011 118 1905 1910 10.1016/j.ophtha.2011.03.033 21764137
72. A highly sensitive method for molecular diagnosis of fungal keratitis: a dot hybridization assay. Kuo MT, Chang HC, Cheng CK, Chien CC, Fang PC, Chang TC, Ophthalmology 2012 119 2434 2442 10.1016/j.ophtha.2012.06.049 22968143
73. Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis. Dabil H, Boley ML, Schmitz TM, Van Gelder RN, Arch Ophthalmol 2001 119 1315 1322 10.1001/archopht.119.9.1315 11545637 (Pubitemid 32994876)
74. Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome. Yamamoto S, Pavan-Langston D, Tada R, Yamamoto R, Kinoshita S, Nishida K, Shimomura Y, Tano Y, Am J Ophthalmol 1995 119 796 798 7785697
75. Global report: UNAIDS Report on the global AIDS epidemic 2012, Available on: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/ 2012/gr2012/20121120-UNAIDS-Global-Report-2012-with-annexes-en.pdf. pp8-15. Accessed 15 June 2013
76. Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long-term study. Kaleemunnisha S, Banu AA, Shrikrishna S, George AE, Babu BR, Devaleenal B, Kumarasamy N, Biswas J, J Ophthalmic Inflamm Infect 2013 3 2 10.1186/1869-5760-3-2 23514612
77. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET Jr, International Syphilis Study Group, Retina 2012 32 1915 1941 22863970
78. Clinical manifestations of human immunodeficiency virus-induced uveitis. Kunavisarut P, Sirirungsi W, Pathanapitoon K, Rothova A, Ophthalmology 2012 119 1455 1459 10.1016/j.ophtha.2012.01.030 22542726
79. HIV-related eye disease in patients presenting to a tertiary care government hospital in Turkey. Akçakaya AA, Sargn F, Erbil HH, Aybar A, Sadigov F, Yaylal SA, Akçay G, Ozgüneş N, Ocul Immunol Inflamm 2012 20 158 162 10.3109/09273948.2012.676701 22515816
80. Intraocular tuberculosis. Cutrufello NJ, Karakousis PC, Fishler J, Albini TA, Ocul Immunol Inflamm 2010 18 281 291 10.3109/09273948.2010.489729 20662660
81. AIDS and Ophthalmology: the. first quarter century. Holland GN, Am J Ophthalmol 2008 145 397 408 10.1016/j.ajo.2007.12.001 18282490 (Pubitemid 351249852)
82. Cytomegalovirus Retinitis in Immunocompetent Patients: Case Reports and Literature Review. Radwan A, Metzinger JL, Hinkle DM, Foster CS, Ocul Immunol Inflamm 2013 Epub ahead of print
83. Uveitis: Diagnostic approach and ancillary analysis. Cunningham ET Jr, Nozik RA, Duane's Ophthalmology, Volume 37 Philadelphia: Lippincott Williams and Wilkins, William T, Jaeger EA, 2007 1 25 23910666
84. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Coupland SE, Bechrakis NE, Anastassiou G, Foerster AM, Heiligenhaus A, Pleyer U, Hummel M, Stein H, Graefes Arch Clin Exp Ophthalmol 2003 241 860 870 10.1007/s00417-003-0749-y 14605902 (Pubitemid 37407899)
85. Diagnosis of a primary uveal extranodal marginal zone B-cell lymphoma by chorioretinal biopsy: case report. Coupland SE, Joussen A, Anastassiou G, Stein H, Graefes Arch Clin Exp Ophthalmol 2005 243 482 486 10.1007/s00417-004-1050-4 15586289 (Pubitemid 40823225)
86. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE, Ophthalmology 2004 111 1762 1767 15350334 (Pubitemid 39179694)
87. Characterization of vitreous B-cell infiltrates in patients with primary ocular lymphoma, using CDR3 size polymorphism analysis of antibody transcripts. Gorochov G, Parizot C, Bodaghi B, Raphael D, Cassoux N, Merle-Beral H, Debré P, LeHoang P, Invest Ophthalmol Vis Sci 2003 44 5235 5241 10.1167/iovs.03-0035 14638722 (Pubitemid 37475394)
88. Ocular and central nervous system lymphoma: clinical features and diagnosis. Cassoux N, Merle-Beral H, Leblond V, Bodaghi B, Miléa D, Gerber S, Fardeau C, Reux I, Xuan KH, Chan CC, LeHoang P, Ocul Immunol Inflamm 2000 8 243 250 10.1076/ocii.8.4.243.6463 11262654 (Pubitemid 32174745)
89. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Cassoux N, Giron A, Bodaghi B, Tran TH, Baudet S, Davy F, Chan CC, LeHoang P, Merle-Béral H, Invest Ophthalmol Vis Sci 2007 48 3253 3259 10.1167/iovs.06-0031 17591896 (Pubitemid 351261171)
90. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB, Am J Ophthalmol 1995 120 671 673 7485372
91. Diagnosis of intraocular lymphoma. Davis JL, Ocul Immunol Inflamm 2004 12 7 16 10.1076/ocii.12.1.7.28072 15209459 (Pubitemid 38406448)
92. Association of interleukin-10 in the vitreous and cerebral spinal fluid and primary central nervous system lymphoma. Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC, Arch Ophthalmol 1997 115 1157 1160 10.1001/archopht.1997.01100160327010 9298057 (Pubitemid 27387952)
93. Vitreous cytokine levels. Wolf LA, Reed GF, Buggage RR, Nussenblatt RB, Chan CC, Ophthalmology 2003 110 1671 1672 10.1016/S0161-6420(03)00811-X 12917196 (Pubitemid 36962510)
94. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Kimura K, Usui Y, Goto H, Japanese Intraocular Lymphoma Study Group, Jpn J Ophthalmol 2012 56 383 389 10.1007/s10384-012-0150-7 22661396
95. Cytokine and molecular analyses of intraocular lymphoma. Ohta K, Sano K, Imai H, Kikuchi T, Ocul Immunol Inflamm 2009 17 142 147 10.1080/ 09273940802702553 19585355
96. Cytopathological analysis of vitreous in intraocular lymphoma. Intzedy L, Teoh SC, Hogan A, Mangwana S, Mayer EJ, Dick AD, Pawade J, Eye 2008 22 289 293 10.1038/sj.eye.6702965 17767143 (Pubitemid 351266473)
97. Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome). Coupland SE, Perez-Canto A, Hummel M, Stein H, Heimann H, Graefes Arch Clin Exp Ophthalmol 2005 243 847 852 10.1007/s00417-005-1166-1 15909161 (Pubitemid 41386706)
98. S-antigen uveitis in primates. A new model for human disease. Nussenblatt RB, Kuwabara T, de Monasterio FM, Wacker WB, Arch Ophthalmol 1981 99 1090 1092 10.1001/archopht.1981.03930011090021 7236108 (Pubitemid 11070436)
99. Human S-antigen determinant recognition in uveitis. de Smet MD, Bitar G, Mainigi S, Nussenblatt RB, Invest Ophthalmol Vis Sci 2001 42 3233 3238 11726628 (Pubitemid 33740685)
100. Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. Dick AD, Int Ophthalmol Clin 2000 40 1 18 11064854 (Pubitemid 30235938)
101. Humoral and cellular immune reactions against retinal antigens in clinical disease. Kijlstra A, Hoekzema R, Vd Lelij A, Doekes G, Rothova A, Curr Eye Res 1990 9 85 89 2200648 (Pubitemid 20295606)
102. Uveitis induced in primates by IRBP: humoral and cellular immune responses. Hirose S, Wiggert B, Redmond TM, Kuwabara T, Nussenblatt RB, Chader GJ, Gery I, Exp Eye Res 1987 45 695 702 10.1016/S0014-4835(87)80118-5 3428394 (Pubitemid 17166198)
103. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Direskeneli H, Rheumatology 2006 45 1461 1465 10.1093/rheumatology/kel329 16998234 (Pubitemid 44817050)
104. Aqueous cytokine changes associated with Posner-Schlossman Syndrome with and without human Cytomegalovirus. Li J, Ang M, Cheung CM, Vania M, Chan AS, Waduthantri S, Yang H, Chee SP, PLoS One 2012 7 44453 10.1371/journal.pone. 0044453 23028541
105. Cytokine and CXC chemokine expression patterns in aqueous humor of patients with presumed tuberculousuveitis. Abu El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SA, Opdenakker G, Geboes K, Van Damme J, Cytokine 2012 59 377 381 10.1016/j.cyto.2012.04.030 22583692
106. Cytokine profiles in toxoplasmic and viral uveitis. Lahmar I, Abou-Bacar A, Abdelrahman T, Guinard M, Babba H, Ben Yahia S, Kairallah M, Speeg-Schatz C, Bourcier T, Sauer A, Villard O, Pfaff AW, Mousli M, Garweg JG, Candolfi EJ, Infect Dis 2009 199 1239 1249 10.1086/597478
107. Iyer JV, Conolly J, Au B, Yeo TK, Agrawal R, Teoh SC, Proteomic analysis of aqueous humor in patients with Cytomegalovirus retinitis Poster: ARVO 2012 Annual Meeting, Fort Lauderdale: Florida, USA 2012
108. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Lucey DR, Clerici M, Shearer GM, Clin Microbiol Rev 1996 9 532 562 8894351 (Pubitemid 26366537)
109. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Jabs DA, Nussenblatt RB, Rosenbaum JT, Am J Ophthalmol 2005 140 509 516 16196117 (Pubitemid 41224845)
110. Case report of cytomegalovirus retinitis in an HIV-positive patient with a CD4-count nadir of 254 cells per μl. Ang BC, Teoh SC, Eye 2012 26 1153 1154 22595905
111. Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts. Fekrat S, Dunn JP, Lee D, Miller T, Jabs DA, Arch Ophthalmol 1995 113 18 10.1001/archopht.1995.01100010020007 7826288
112. Association of birdshot retinochoroidopathy and HLA-A29 antigen. Baarsma GS, Priem HA, Kijlstra A, Curr Eye Res 1990 9 63 68 10.3109/02713689008999422 2384016 (Pubitemid 20295603)
113. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE, Am J Ophthalmol 1982 94 147 158 6956239 (Pubitemid 12038546)
114. HLA-A29. 2 subtype associated with birdshot retinochoroidopathy. LeHoang P, Ozdemir N, Benhamou A, Tabary T, Edelson C, Betuel H, Semiglia R, Cohen JH, Am J Ophthalmol 1992 113 33 35 1728143
115. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behcet's disease. Yasuoka H, Okazaki Y, Kawakami Y, Hirakata M, Inoko H, Ikeda Y, Kuwana M, Arthritis Rheum 2004 50 3658 3662 10.1002/art.20597 15529349 (Pubitemid 39488694)
116. Close association of HLA-Bw51 with Behçet's disease. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M, Arch Ophthalmol 1982 100 1455 1458 10.1001/archopht.1982.01030040433013 6956266 (Pubitemid 12055531)
117. Ophthalmological significance of HLA associated uveitis. Feltkamp TE, Eye 1990 4 839 844 10.1038/eye.1990.133 2101117
118. HLA typing in uveitis: use and misuse. Zamecki KJ, Jabs DA, Am J Ophthalmol 2010 149 189 193 10.1016/j.ajo.2009.09.018 20103052
119. Clinical features and prognosis of HLA B27-associated acute anterior uveitis in an Italian patient population. Accorinti M, Iannetti L, Liverani M, Caggiano C, Gilardi M, Ocul Immunol Inflamm 2010 18 91 96 10.3109/ 09273941003597268 20370333
120. Clinical features and prognosis of HLA-B27 positive and negative anterior uveitis in a Korean population. Park SC, Ham DI, J Korean Med Sci 2009 24 722 728 10.3346/jkms.2009.24.4.722 19654959